Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251696 | SCV000301571 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000357381 | SCV000429362 | uncertain significance | Primary hyperoxaluria | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000974765 | SCV001122623 | likely benign | not provided | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000974765 | SCV004149693 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | AGXT: BP4, BP7 |
Clinical Biochemistry Laboratory, |
RCV000186244 | SCV000239568 | uncertain significance | Primary hyperoxaluria, type I | 2014-11-27 | no assertion criteria provided | research | |
Natera, |
RCV000186244 | SCV001462985 | likely benign | Primary hyperoxaluria, type I | 2020-05-02 | no assertion criteria provided | clinical testing |